{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:31:52Z","timestamp":1780363912576,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jpba.2024.116175","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T01:27:02Z","timestamp":1713922022000},"page":"116175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Technical and health governance aspects of the external quality assessment system for classical and new psychoactive substances analysis testing in blood"],"prefix":"10.1016","volume":"245","author":[{"given":"Francesca","family":"Di Gaudio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Cucina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Indelicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Brunacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lundari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Rotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116175_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/15563650.2013.768344","article-title":"Cross-reactivity studies and predictive modeling of \u201cBath Salts\u201d and other amphetamine-type stimulants with amphetamine screening immunoassays","volume":"51","author":"Petrie","year":"2013","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"30","key":"10.1016\/j.jpba.2024.116175_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jpba.2018.10.011","article-title":"Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices","volume":"163","author":"Graziano","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116175_bib3","first-page":"351","article-title":"NPS: medical consequences associated with their intake","volume":"32","author":"Schifano","year":"2017","journal-title":"Neuropharmacol. N. Psychoact. Subst. (NPS) Curr. Top. Behav. Neurosci."},{"issue":"10","key":"10.1016\/j.jpba.2024.116175_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpba.2016.07.009","article-title":"A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS\/MS and application to real cases","volume":"129","author":"Vaiano","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116175_bib5","first-page":"207","article-title":"Novel psychoactive substances (NPS) and recent scenarios: epidemiological, anthropological and clinical pharmacological issues","volume":"17","author":"Corkery","year":"2018","journal-title":"Light Forensic Sci.: Issues Appl."},{"key":"10.1016\/j.jpba.2024.116175_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13181-013-0314-y","article-title":"2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing","volume":"10","author":"Stellpflug","year":"2014","journal-title":"J. Med. Toxicol."},{"issue":"7","key":"10.1016\/j.jpba.2024.116175_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jat\/bkaa089","article-title":"Screening of 104 new psychoactive substances (NPS) and other drugs of abuse in oral fluid by LC\u2013MS-MS","volume":"44","author":"da Cunha","year":"2020","journal-title":"J. Anal. Tox."},{"key":"10.1016\/j.jpba.2024.116175_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.forsciint.2017.08.031","article-title":"The analysis of 132 novel psychoactive substances in human hair using a single step extraction by tandem LC\/MS","volume":"279","author":"Vassiliki","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.jpba.2024.116175_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/dta.3170","article-title":"Development and validation of a rapid LC-MS\/MS method for the detection of 182 novel psychoactive substances in whole blood","volume":"14","author":"Giorgetti","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116175_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","article-title":"Development and application of a multi-component LC\u2013MS\/MS method for determination of designer benzodiazepines in urine","volume":"1035","author":"Bergstrand","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116175_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110595","article-title":"A comprehensive analytical process, from NPS threat identification to systematic screening: method validation and one-year prevalence study","volume":"318","author":"Garneau","year":"2021","journal-title":"Forensic Sci. Int."},{"issue":"5","key":"10.1016\/j.jpba.2024.116175_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/1570159X15666161111112545","article-title":"Recent trends in analytical methods to determine new psychoactive substances in hair","volume":"15","author":"Kyriakou","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2024.116175_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jchromb.2014.08.033","article-title":"Simultaneous Detection of 93 Conventional and Emerging Drugs of Abuse and Their Metabolites in Urine by UHPLC-MS\/MS","volume":"969","author":"Tang","year":"2014","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116175_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.124816","article-title":"Identification of new psychoactive substances and their metabolites using non-targeted detection with high-resolution mass spectrometry through diagnosing fragment ions\/neutral loss analysis","volume":"265","author":"Matey","year":"2023","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.jpba.2024.116175_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/dta.2535","article-title":"Development of a sensitive untargeted liquid chromatography\u2013high resolution mass spectrometry screening devoted to hair analysis through a shared MS2 spectra database: a step toward early detection of new psychoactive substances","volume":"11","author":"Fabresse","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116175_bib16","unstructured":"\u3008https:\/\/www.unodc.org\/documents\/scientific\/NPS_Report.pdf\u3009 28.02.2024."},{"issue":"3","key":"10.1016\/j.jpba.2024.116175_bib17","first-page":"S80","article-title":"Targeted and untargeted screening of new psychoactive substances (NPS) and classical drugs of abuse in Paris using hair testing: a 10-years study (2012\u20132021)","volume":"34","author":"Dugues","year":"2022","journal-title":"Toxicol. Anal. Et. Clin."},{"issue":"2-3","key":"10.1016\/j.jpba.2024.116175_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.forsciint.2004.11.025","article-title":"Proficiency testing (external quality assessment) of drug detection in oral fluid","volume":"150","author":"Clarke","year":"2005","journal-title":"Forensic Sci. Int."},{"issue":"1-3","key":"10.1016\/j.jpba.2024.116175_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2008.09.016","article-title":"ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007.\"","volume":"182","author":"Ventura","year":"2008","journal-title":"Forensic Sci. Int."},{"issue":"15-16","key":"10.1016\/j.jpba.2024.116175_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cca.2010.03.031","article-title":"External quality assessment of multi-analyte chromatographic methods in oral fluid","volume":"411","author":"Pil","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"1-3","key":"10.1016\/j.jpba.2024.116175_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2011.10.005","article-title":"The standardization of results on hair testing for drugs of abuse: An interlaboratory exercise in Lombardy Region, Italy","volume":"218","author":"Stramesi","year":"2012","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.jpba.2024.116175_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.011","article-title":"Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: a cross sectional study by hair testing (2012\u20132017).\"","volume":"204","author":"Larabi","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.jpba.2024.116175_bib23","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.3390\/ijerph20054628","article-title":"Challenges in drug surveillance: strengthening the analysis of new psychoactive substances by harmonizing drug checking services in proficiency testing","volume":"20","author":"Balcaen","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.jpba.2024.116175_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00518-6","article-title":"Role of external quality assurance schemes in assessing and improving quality in medical laboratories","volume":"309","author":"Libeer","year":"2001","journal-title":"Clin. Chim. Acta"},{"issue":"2-3","key":"10.1016\/j.jpba.2024.116175_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.forsciint.2004.04.025","article-title":"HAIRVEQ: an external quality control scheme for drugs of abuse analysis in hair","volume":"145","author":"Pichini","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116175_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cca.2013.12.032","article-title":"The role of external quality assessment schemes in monitoring and improving the standardization process","volume":"432","author":"Ceriotti","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2024.116175_bib27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1570159X1709190729101751","article-title":"New psychoactive substances: a matter of time","volume":"17","author":"Pantano","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"184","key":"10.1016\/j.jpba.2024.116175_bib28","first-page":"1","article-title":"Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair","volume":"7","author":"Busard\u00f2","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.jpba.2024.116175_bib29","first-page":"6008","article-title":"The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances","volume":"23","author":"Zaami","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.jpba.2024.116175_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1515\/cclm-2022-0780","article-title":"Technical and health governance aspects of the external quality assessment scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a regional health service","volume":"61","author":"Di Gaudio","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpba.2024.116175_bib31","first-page":"1","article-title":"The growing problem of new psychoactive substances (NPS).\u00a0Neuropharmacology of New Psychoactive Substances (NPS)","author":"Madras","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.jpba.2024.116175_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1570159X14666161220154550","article-title":"\"New psychoactive substances (NPS), a new global issue: neuropharmacological, chemical and toxicological aspects.\"","volume":"15","author":"Pichini","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2024.116175_bib33","unstructured":"ICE Drug Analysis Report, 2022, UNODC."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T23:47:48Z","timestamp":1720655268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"alternative-id":["S0731708524002152"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116175","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technical and health governance aspects of the external quality assessment system for classical and new psychoactive substances analysis testing in blood","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116175"}}